These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11851771)
1. Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma. Kirkali Z; Yorukoglu K; Ozkara E; Kazimoglu H; Mungan U Int J Urol; 2001 Dec; 8(12):697-703. PubMed ID: 11851771 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nuclear morphometry in renal cell carcinoma. Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763 [TBL] [Abstract][Full Text] [Related]
3. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of sarcomatoid histology and volume-weighted mean nuclear volume in renal cell carcinoma. Kanamaru H; Sasaki M; Miwa Y; Akino H; Okada K BJU Int; 1999 Feb; 83(3):222-6. PubMed ID: 10233484 [TBL] [Abstract][Full Text] [Related]
5. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491 [TBL] [Abstract][Full Text] [Related]
6. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
7. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369 [TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
9. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis. Mehdi MZ; Nagi AH; Naseem N Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114 [TBL] [Abstract][Full Text] [Related]
10. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma. Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma. Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925 [TBL] [Abstract][Full Text] [Related]
16. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma. Ku JH; Moon KC; Kwak C; Kim HH Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221 [TBL] [Abstract][Full Text] [Related]
17. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627 [TBL] [Abstract][Full Text] [Related]
18. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma. Oda T; Takahashi A; Miyao N; Yanase M; Masumori N; Itoh N; Sato MA; Kon S; Tsukamoto T Int J Urol; 2003 Jan; 10(1):13-8. PubMed ID: 12534920 [TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597 [TBL] [Abstract][Full Text] [Related]
20. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma. Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]